India’s Biological E. to Begin Phase III Trial of Vaccine
India's Biological E. Ltd will soon begin its phase III trials of COVID-19 vaccine and plans producing 75 million to 80 million doses a month from August.
The Managing Director, Mahima Datla said the company has developed the vaccine…